On February 22, 2012, experts of the World Health Organization (WHO) and the United States Pharmacopoeia Convention (USP) visited YRPG. Chairman Xu Jingren welcomed them.
On the meeting, Xu Jingren told the experts that YRPG would always bear the company philosophy of "seeking progress all the time and safeguardinghealth for all human being", dedicating to improving the level of health of all mankind. To serve more people outside China, YRPG plannedto strengthen cooperation with WHO, and strivedto be one of WHO's qualified suppliers. The WHO procurement manager also introduced how WHO pre-qualifiedmedicines. The manager indicated that YRPG's mission was in accordance with that of WHO, so WHO's GDF wouldtake YRPG's application for medicine pre-qualification into consideration to work together for protecting public health worldwide.
The experts also inspected the second workshop of solid dosage, materials warehouse and central lab. They were impressed by YRPG's advanced production facilities and quality management concepts. They expressed their anticipation for future cooperation.
Many Chinese pharmaceutical manufacturers aimed toparticipate in the global procurement. However, to enter the list of medicine suppliers of international organizations, Chinese pharmaceutical manufacturers have tobe pre-qualified by WHO, as medicines werespecial goods. During the pre-qualification process, manufacturers and their medicines wouldbe strictly reviewed by the Quality Assurance and Safety of Medicines (QSM), a branch of the Department of Essential Medicines and Pharmaceutical Policies in WHO. Once manufacturers passed the pre-qualification, they couldparticipate in medicine biddings held by international intermediaries. In addition, it was easy for the manufacturers to register medicines in western countries, and obtain assistance from WHO experts and advisers.